PegBio Co.
Latest round
- Series D
Last raised
- Jun 2014
Total raised
- $3.1M
Investors
- 3
About PegBio Co.
, Ltd. is a biopharmaceutical company that focuses on the research and development of innovative drugs for diabetes and obesity., later was converted into a joint stock company in 2020., Ltd. upon redomiciling its registered office to Hangzhou. In May 2025, the company completed its initial public offering on the Hong Kong Stock Exchange. PegBio's drug pipeline focus on the development of long-acting peptide drugs for metabolic and endocrine diseases, including PB-119, PB-718, PB-401 and others. The company generates revenue mainly from commercialization of drugs and licensing agreements for pipeline products.
Who invested in PegBio Co.
3 investors across 4 rounds
See all investors in PegBio Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about PegBio Co.
Who invested in PegBio Co.?
PegBio Co. has 3 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has PegBio Co. raised?
PegBio Co. has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did PegBio Co. last raise money?
PegBio Co.'s most recent round on record is a Series D, in Jun 2014.
What does PegBio Co. do?
PegBio Co. is a pharmaceuticals company.
Where is PegBio Co. headquartered?
PegBio Co. is headquartered in Hangzhou, China.
Which VCs invest in companies like PegBio Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at PegBio Co.'s stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series D
Raising like PegBio Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.